Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Lancet HIV. 2022 Oct;9(10):e700–e708. doi: 10.1016/S2352-3018(22)00219-3

Table 2.

Incidence rates per 100,00 person-years for lung cancer in people living with HIV during 2001–2016.

2001–2004 2005–2008 2009–2012 2013–2016
Age group

20–39 13·0 (10·9–15·1) 7·9 (6·4–9·3) 5·2 (4·1–6·3) 2·1 (1·2–3·1)
40–49 73·2 (68·2–78·1) 56·8 (53·3–60·2) 42·0 (39·2–44·7) 23·6 (20·5–26·8)
50–59 210·3 (197·4–223·1) 162·1 (154·2–169·9) 126·1 (120·7–131·4) 103·3 (96·7–109·9)
60–69 401·0 (362·6–439·4) 325·6 (303·1–348·1) 261·5 (247·4–275·6) 206·0 (190·3–221·8)
70+ 464·7 (373·5–555·8) 429·1 (372·3–485·9) 344·6 (308·7–380·5) 350·2 (305·0–395·4)

*Overall 124·4 (114·5–135·0) 97·9 (91·8–104·3) 76·1 (71·9–80·4) 58·3 (53·4–63·5)
*

Age-standardized using the age distribution of people living with HIV in 2010

95% confidence interval in paratheses